These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2891470)

  • 1. Accuracy of C-peptide:insulin molar ratio as a measure of hepatic removal of insulin.
    Berzins R; Wieczorek KR; Rajotte RV; Molnar GD; Tam YK; McGregor JR; Fawcett DM
    Diabetes Res Clin Pract; 1987 Nov; 4(1):37-43. PubMed ID: 2891470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of somatostatin on insulin and glucose levels during insulin infusion in anesthetized dogs.
    O'Brien DW; Molnar GD; Petersen TD; Rajotte RV
    Pancreas; 1990 Nov; 5(6):652-7. PubMed ID: 1980734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic approach to the estimation of hepatic removal of insulin.
    Berzins R; Tam YK; Molnar GD; Rajotte RV; Wieczorek KR; McGregor JR; Fawcett DM
    Pancreas; 1986; 1(6):544-9. PubMed ID: 3550790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics.
    Vølund A; Polonsky KS; Bergman RN
    Diabetes; 1987 Oct; 36(10):1195-202. PubMed ID: 2888696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The limitations to and valid use of C-peptide as a marker of the secretion of insulin.
    Polonsky K; Frank B; Pugh W; Addis A; Karrison T; Meier P; Tager H; Rubenstein A
    Diabetes; 1986 Apr; 35(4):379-86. PubMed ID: 3514322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.
    Bratusch-Marrain PR; Waldhäusl WK; Gasić S; Hofer A
    Metabolism; 1984 Feb; 33(2):151-7. PubMed ID: 6141519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.
    Polonsky KS; Pugh W; Jaspan JB; Cohen DM; Karrison T; Tager HS; Rubenstein AH
    J Clin Invest; 1984 Nov; 74(5):1821-9. PubMed ID: 6389599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.
    Polonsky K; Jaspan J; Pugh W; Cohen D; Schneider M; Schwartz T; Moossa AR; Tager H; Rubenstein AH
    J Clin Invest; 1983 Sep; 72(3):1114-23. PubMed ID: 6350363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hepatic insulin influx on insulin retention: comparison of net flux and per cent extraction as indices of hepatic insulin retention.
    Wieczorek KR; Rajotte RV; Molnar GD; McGregor JR; Lussier BT; Fawcett DM
    Clin Invest Med; 1985; 8(4):257-63. PubMed ID: 2866858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses.
    Tóth F; Frank N; Martin-Jiménez T; Elliott SB; Geor RJ; Boston RC
    Equine Vet J; 2010 Mar; 42(2):149-55. PubMed ID: 20156251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin.
    Saccà L; Orofino G; Petrone A; Vigorito C
    J Clin Endocrinol Metab; 1984 Aug; 59(2):191-6. PubMed ID: 6145721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule.
    Hovorka R; Koukkou E; Southerden D; Powrie JK; Young MA
    Diabetologia; 1998 May; 41(5):548-54. PubMed ID: 9628272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin increases hepatic insulin extraction.
    O'Brien DW; Rajotte RV; Molnar GD; Toth K; Petersen TD
    Diabetes Res; 1988 Apr; 7(4):171-8. PubMed ID: 2900090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects.
    Waldhäusl WK; Gasić S; Bratusch-Marrain P; Korn A; Nowotny P
    Am J Physiol; 1982 Dec; 243(6):E476-82. PubMed ID: 6756164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
    Luzi L; DeFronzo RA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
    Shiota M; Galassetti P; Monohan M; Neal DW; Cherrington AD
    Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.
    Polonsky KS; Rubenstein AH
    Diabetes; 1984 May; 33(5):486-94. PubMed ID: 6373457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.